期刊文献+

IFN-α对体外培养CML-DC功能、表达趋化因子及其受体的影响 被引量:2

Influence of IFN-α on Function of CML-DC in vitro and Expression of Chemokine with Its Receptor
下载PDF
导出
摘要 为了研究α干扰素(IFN-α)对慢性粒细胞白血病(CML)来源的树突状细胞(DC)分泌趋化因子、表达趋化因子受体及其功能的影响,取13例CML慢性期患者骨髓单个核细胞,在小牛血清培养体系中诱导培养CML来源的DC,以rhSCF、rhFlt3L作为扩增体系的细胞因子,加入rhGMCSF、rhTNFα、rhIL4,加或不加rhIFN-α诱导DC的生成,培养2周后流式细胞术检测培养细胞的免疫表型,ELISA法检测培养上清液中CMLDC分泌MIP3-β的含量,MTT法检测CMLDC刺激健康人外周血T淋巴细胞增殖能力。结果表明:IFN-α组培养所获DC表面CD86、CD83、CD40、MHCⅠ类分子、CCR7的表达均高于对照组(P<0.01);IFN-α组诱导培养的CMLDC表达MIP3β较对照组明显增高(P<0.01);IFN-α组诱导培养的CMLDC刺激异体T淋巴细胞增殖的能力较对照组明显增强(P<0.01)。结论:IFN-α可能部分通过纠正CMLDC的免疫表型以加速CMLDC的成熟,增强CMLDC的功能。 To study the influence of IFN-α on function of CML-DC cultured in vitro and expression of chemokine and its chemokine receptor, bone marrow mononuclear cells from 13 CML patients were cultured in the fetal calf serum culture system supplemented with rhSCF, rhFlt-3L for expansion system, and adding rhGM-CSF, rhTNF-α, rhIL-4, with or without rhIFN-α to induce DCs. After incubation for two weeks, the phenotypes of CML-DC were analyzed by direct immunofluorescence and flow cytometry. The concentration of MIP-3β expressed by CML-DC in the supernatant were analyzed by ELISA. The proliferative ability of T cells from healthy volunteers stimulated by CML-DCs were measured by MTT assay. The results showed that expression of CD86, CD83, CD40, MHC-I class molecules, CCR7, the concentration of MIP-3β expressed by CML-DC, and the proliferative ability of T cells stimulated by CML-DCs in IFN-α group were all significantly higher than that in control group (P<0.01). It is concluded that the immunophenotype of CML-DCs can be partially changed by IFN-α to accelerate the maturation of CML-DCs, enhance the capacity of CML-DCs, and stimulate allogeneic T lymphocyte proliferation.
出处 《中国实验血液学杂志》 CAS CSCD 2005年第3期488-491,共4页 Journal of Experimental Hematology
关键词 树突状细胞 慢性粒细胞白血病 Α-干扰素 趋化因子 趋化因子受体 dendritic cell chronic myeloid leukemia interferon-α chemokine chemokine receptor
  • 相关文献

参考文献17

  • 1Chen X, Regn S, Raffegerst S, et al. Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia. Br J Haematol, 2000 , 111 : 596 - 607.
  • 2Le-Bon A, Schiavoni G, D'Agostino G, et al. Type 1 interferon potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immmunity, 2001, 14:461 -470.
  • 3Montoya M, Schiavoni G, Mattei F, et al. Type I interferon produced by dendritic cells promote their phenotypic and functional activation. Blood,2002,99:3263-3271.
  • 4Wang C, AI-Omar HM, Radvanyi L, et al. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN -α.Exp Hematol , 1999, 27:1176-1184.
  • 5Barratt-Boyes SM, Zimmer MI, Harshyne LA, et al. Maturation and trafficking of manocyte - derived dendritic cells in monkeys : implications for dendritic cell-based vaccines. J I mmunol, 2000, 164:2487- 2495.
  • 6Sozzani S, Allavena P, Vecchi A, et al. Chemokines and dendritic cell traffic. J Clin Immunol, 2000,20:151 -160.
  • 7Zlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity, Immunity ,2000 , 12 : 121 - 127.
  • 8Penna G, Vulcano M, Sozzani S, et al. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol, 2002, 63:1164 -1171.
  • 9Sallusto F, Palermo B, Lenig D, et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function, Eur J Immunol, 1999 ,29:1617 - 1675.
  • 10Paquette RL, Hsu N, Said J, et al. Interferon-or induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo,Leukemia, 2002 , 16 : 1484 - 1489.

同被引文献13

  • 1刘煜,陈家伟,杨金奎,刘超,刘翠萍,张梅.趋化因子受体CCR5、CCR3在1型糖尿病患者中的表达[J].中华内分泌代谢杂志,2004,20(5):428-431. 被引量:3
  • 2杜昊,张连生,柴晔,张玉芳,曾鹏云.流感疫苗对慢性粒细胞白血病源性树突状细胞功能影响的研究[J].白血病.淋巴瘤,2006,15(1):10-12. 被引量:1
  • 3Laxmanan S, Robertson SW, Wang E, et al. Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways [J]. Biochem Biophys Res Commun, 2005, 334(1) : 193-198.
  • 4Westers TM, Houtenbos I, Snoijs NC, et al. Leukemia-derived dendritic cells in acute myeloid leukemia exhibit potent migratory capacity [J]. Leukemia, 2005, 19(7): 1270-1272.
  • 5Boissel N, Rousselot P, Raffoux E, et al. Defective blood dendritie cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate [J]. Leukemia, 2004, 18(10) : 1656-1661.
  • 6Dikov MM, Ohm JE, Ray N, et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation [J]. J Immunol, 2005, 174(1): 215-222.
  • 7Gabrilovich DI, Ishida T, Nadaf S, et al. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function [J]. Clin Cancer Res, 1999, 5(10): 2963-2970.
  • 8Nair S, Boezkowski D, Moeller B, et al. Synergy between tumor immunotherapy and anti-angiogenie therapy [J]. Blood, 2003, 102 (3) :964-971.
  • 9宋向凤,郭继强,白国强,王辉.蝎素组分Ⅲ对Jurkat细胞CCR5表达的影响[J].中国免疫学杂志,2009,25(3):221-222. 被引量:5
  • 10丁红晖,郝友华,杨东亮.淋巴细胞相关趋化因子及其受体与慢性病毒性肝炎[J].细胞与分子免疫学杂志,2009,25(8):764-765. 被引量:2

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部